Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2009
11/18/2009CN100560090C Methods of acquiring total tanshinone and total phenolic acid
11/18/2009CN100560089C Traditional Chinese medicine formulated product used for treating osteosporosis
11/18/2009CN100560088C Use of sophora alapecuroides in preparing medicament for treating zoster
11/18/2009CN100560086C Application of Chinese medicine balloonflower as in-vitro spermaticide and method for preparing the medicament
11/18/2009CN100560084C Method and preparations having effect against allergic symptoms
11/18/2009CN100560082C Medical application of fruit extraction of miracle fruit
11/18/2009CN100560080C Composition containing nucleoside and its preparing method
11/18/2009CN100560077C Pharmaceutical composition and its preparation method and uses
11/18/2009CN100560074C External patch containing estrogen and/or progestogen
11/18/2009CN100560072C Hydrochloric acid olprinone injection and method for preparing the same
11/18/2009CN100560069C Mitiglinide calcium formulation and its detection method
11/18/2009CN100560068C Levogyration sulpiride injection preparation method
11/18/2009CN100560067C Hydrochloric acid dronedarone medicinal compositions for oral use and method for preparing the same
11/18/2009CN100560066C Preparation method of a compound glutamine medicine composition
11/18/2009CN100560065C Asarone fatty emulsion and its preparing method
11/18/2009CN100560064C Method for preparing flupentixol and melitracen capsule
11/18/2009CN100560063C Pill preparation of 'Shen Bao', its preparation method and quality control method
11/18/2009CN100560062C Clindamycin phosphate freeze-dried powder needle and preparation thereof
11/18/2009CN100560061C Lornoxicam freeze-dried injection and preparation method thereof
11/18/2009CN100560060C Nano-grade medicine microball and preparation process thereof
11/18/2009CN100560059C Co-grinding process for the preparation of a ternary composition
11/18/2009CN100560058C Fast-effective oral analgesic
11/18/2009CN100560057C Wound-protection liquid, and its preparing method
11/18/2009CN100560056C Compound all-trans retinoic acid cream and its preparation method and application
11/18/2009CN100560055C Ophthalmic gel and its preparation method
11/17/2009US7619066 IL-1ra variants
11/17/2009US7619007 Provides pharmaceutical compositions that are administered so as to deliver to a subject, an amount of an NMDAr antagonist that is high enough to treat symptoms or damaging effects of an underlying disease while avoiding undesirable side effects, particularly CNS side effects
11/17/2009US7619002 Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
11/17/2009US7619001 Utilization of dialkylfumarates
11/17/2009US7618659 Isolating 2S canola protein from canola oil seed meal
11/17/2009US7618653 Biological artificial nerve guide and method of making
11/17/2009US7618651 gel comprising glycerol formal solvent, hydroxypropyl methylcellulose and a dissolved antibacterial agent Tobramycin, antifungal agent Terbinafine , and a steroid Betamethasone; controlled- or sustained-release; treating microbial infection of the skin, ear, or eye, especially for veterinary medicine
11/17/2009US7618650 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
11/17/2009US7618649 For therapy of nasal and non-nasal symptoms of perennial and seasonal allergic rhinitis
11/17/2009US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009US7618641 Functionally reconstituted viral membranes containing adjuvant
11/17/2009US7618620 Artificial tears or vehicles for ophthalmic drugs; viscosity; hydroxypropyl methylcellulose and a combination of two other polymers: guar gum, a carboxyvinyl polymer (polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol), hydroxyethyl cellulose or dextran
11/17/2009US7618619 For use in ocular surgery; containing a vital dyes, especially a disazo dye, that does not diffuse out of the visco-elastic composition.
11/17/2009US7618615 Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
11/17/2009US7618565 Liposome encapsulated hydrogels
11/17/2009US7618412 Method and apparatus for the delivery of contrast fluid to a patient
11/17/2009US7618394 Needleless syringe using supersonic gas flow for particle delivery
11/17/2009CA2554346C Parenteral formulations comprising a beta-cyclodextrin and a preservative
11/17/2009CA2483859C Method of preparing porous calcium phosphate granules
11/17/2009CA2444551C Microprojection array immunization patch and method
11/17/2009CA2406269C Process for drying amoxicillin
11/17/2009CA2402524C Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate
11/17/2009CA2396273C Aerosol inhaler
11/17/2009CA2379365C Transnasal anticonvulsive compositions and modulated process
11/17/2009CA2376850C Topical formulations comprising skin penetration agents and the use thereof
11/17/2009CA2374606C Transdermal device for the application of testosterone or one of the derivatives thereof
11/17/2009CA2351814C Taste masked pharmaceutical particles
11/17/2009CA2341429C Treatment of mucus hypersecretion
11/17/2009CA2339090C Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
11/17/2009CA2338457C Preparation of aqueous clear solution dosage forms with bile acids
11/17/2009CA2304973C Stabilized preparations for use in nebulizers
11/17/2009CA2288694C Active vitamin d3 emulsion lotion
11/17/2009CA2265952C Injection formulations of avermectins and milbemycins
11/17/2009CA2258483C Biocompatible devices with foam scaffolds
11/17/2009CA2157577C Growth differentiation factor-8
11/12/2009WO2009137689A2 Delivery of nucleic acid complexes from particles
11/12/2009WO2009137648A1 Multilayer proton pump inhibitor tablets
11/12/2009WO2009137611A2 Treatment of pulmonary fungal infection with voriconazole via inhalation
11/12/2009WO2009137592A2 Surface-modified nanoparticles
11/12/2009WO2009137100A2 Proguanil to treat skin/mucosal diseases
11/12/2009WO2009137087A2 A method for preventing or alleviating the noxious effects resulting from toxicant exposure
11/12/2009WO2009136982A2 Self-injection guide tablet
11/12/2009WO2009136884A2 Metformin-pioglitazone formulation with antihyperglycemic effects
11/12/2009WO2009136677A1 Gel composition comprising minoxidil
11/12/2009WO2009136408A1 Synergistic pharmaceutical cocrystals
11/12/2009WO2009136370A1 Parenteral supplement with traceelemξntsfor treatment of i. a. sirs, burns selenium-defenciencies
11/12/2009WO2009136336A2 Medical microbubble generation
11/12/2009WO2009136233A1 Aluminium phosphate nanoparticles
11/12/2009WO2009136179A1 Topical compositions
11/12/2009WO2009136056A2 High-fluidity and non-caking pulverulent crystalline maltitol composition
11/12/2009WO2009135951A2 Process for preparing a tablet comprising metformin
11/12/2009WO2009135950A2 Process for preparing a tablet containing excipients
11/12/2009WO2009135949A2 Process for preparing a very high drug load tablet
11/12/2009WO2009135948A2 Process for preparing a high drug load tablet
11/12/2009WO2009135947A2 Process for preparing a low drug load tablet
11/12/2009WO2009135946A1 Method and apparatus for dry granulation
11/12/2009WO2009135855A2 Encapsulation of biologically active agents
11/12/2009WO2009135854A2 Encapsulation of biologically active agents
11/12/2009WO2009135853A2 Encapsulation of biologically active agents
11/12/2009WO2009135852A2 Encapsulation of biologically active agents
11/12/2009WO2009135846A1 Opioid composition for treating skin lesions
11/12/2009WO2009135680A1 Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
11/12/2009WO2009135649A1 Granulate comprising escitalopram oxalate
11/12/2009WO2009135646A2 Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
11/12/2009WO2009135623A1 Pharmaceutical comprising galanthamine having controlled release
11/12/2009WO2009135593A2 Solid pharmaceutical formulation with delayed release
11/12/2009WO2009135520A1 Sustained release microtablets comprising tolterodine tartrate
11/12/2009WO2009135432A1 The use of salvianolic acid b on anti- thrombus
11/12/2009WO2009135423A1 Pharmceuttical composition for treating cardio-cerebro vascular diseases and preparative method and kit thereof
11/12/2009WO2009135336A1 Stretchable cosmetic mask
11/12/2009WO2009117584A3 Anti-inflammatory drug delivery system
11/12/2009WO2009115967A3 Method for the synthesis of hollow spheres
11/12/2009WO2009111852A3 Solid lipid nanoparticles containing retinoids
11/12/2009WO2009111159A3 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
11/12/2009WO2009111088A3 Antitumor immunization by liposomal delivery of vaccine to the spleen
1 ... 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 ... 2991